Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aramchol PK Study in Healthy Volunteers
NCT03774173Phase 1Completed
- Sponsor
- Galmed Pharmaceuticals
- Start
- Dec 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aramchol in Nonalcoholic steatohepatitis (NASH) (2 arms), sponsored by Galmed Pharmaceuticals. Primary endpoint: Pharmacokinetics of aramchol at Day 10. Started Dec 2018; status: completed.
02
Drugs
aramchol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03774173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774173.